Press Release

Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials

Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase...

Jul 16, 2025

Oragenics Inc. (NYSE American: OGEN), a biotechnology firm specializing in intranasal therapeutics for brain-related conditions, has announced a manufacturing agreement...

Read More →
Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials

Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase...

Jul 16, 2025

Oragenics Inc. (NYSE American: OGEN), a biotechnology firm specializing in intranasal therapeutics for brain-related conditions, has announced a manufacturing agreement...

Read More →
Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials

Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase...

Jul 16, 2025

Oragenics Inc. (NYSE American: OGEN), a biotechnology firm specializing in intranasal therapeutics for brain-related conditions, has announced a manufacturing agreement...

Read More →
TBC Uzbekistan Named Among Global Fintech Leaders by CNBC and Statista

TBC Uzbekistan Named Among Global Fintech Leaders by CNBC and Statista

Jul 16, 2025

TBC Uzbekistan has been acknowledged as one of the world’s leading fintech companies in the neobanking category by CNBC and...

Read More →
TBC Uzbekistan Named Among Global Fintech Leaders by CNBC and Statista

TBC Uzbekistan Named Among Global Fintech Leaders by CNBC and Statista

Jul 16, 2025

TBC Uzbekistan has been acknowledged as one of the world’s leading fintech companies in the neobanking category by CNBC and...

Read More →
TBC Uzbekistan Named Among Global Fintech Leaders by CNBC and Statista

TBC Uzbekistan Named Among Global Fintech Leaders by CNBC and Statista

Jul 16, 2025

TBC Uzbekistan has been acknowledged as one of the world’s leading fintech companies in the neobanking category by CNBC and...

Read More →
Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

Jul 16, 2025

A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that the herpes...

Read More →
Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

Jul 16, 2025

A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that the herpes...

Read More →
Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

Jul 16, 2025

A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that the herpes...

Read More →
NanoViricides, Inc. Advances MPox Treatment Amid WHO’s Extended Global Health Emergency

NanoViricides, Inc. Advances MPox Treatment Amid WHO’s Extended Global Health Emergency

Jul 16, 2025

NanoViricides, Inc. (NYSE American: NNVC), a leader in the development of host-mimetic nanomedicine, has reaffirmed its commitment to combating the...

Read More →